Innovations in topical therapy

Bailliere's Clinical Gastroenterology

Volumn 11, Issue 1, 1997, Pages 97-109

  Richter, Frank ^a   Scheppach, Wolfgang ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Bismuth; Budesonide; Corticosteroids; Distal ulcerative colitis; Enema; Lidocaine; Mesalazine; Short chain fatty acids; Topical therapy

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; BECLOMETASONE DIPROPIONATE; BISMUTH DERIVATIVE; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOSPORIN; ENEMA; HYDROCORTISONE; LOCAL ANESTHETIC AGENT; MESALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; SHORT CHAIN FATTY ACID; SUCRALFATE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAINTENANCE THERAPY; META ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TOPICAL DRUG ADMINISTRATION; TOPICAL TREATMENT; ULCERATIVE COLITIS;

EID: 0030914411     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(97)90056-7     Document Type: Article

References (82)

1. Andreoli A, Spinella S, Levenstein S & Prantera C (1994) 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis. Italian Journal of Gastroenterology 26: 121-125.
2. Arlander E, Öst Å, Ståhlberg D & Löfberg R (1996) Ropivacaine gel in active distal ulcerative colitis and proctitis - a pharmacokinetic and exploratory clinical study. Alimentary Pharmacology and Therapeutics 10: 73-81.
3. Azad Khan AK, Piris J & Truelove SC (1977) An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet ii: 892-895.
4. Barber GB, Lee DE, Antonioli DA et al (1985) Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas. American Journal of Gastroenterology 80: 612-614.
5. Bianchi Porro G, Ardizzone S, Petrillo M et al (1995) Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study. American Journal of Gastroenterology 90: 736-739.
6. Biddle WL & Miner PB (1990) Long-term use of mesalamine enemas to induce remission in ulcerative colitis. Gastroenterology 99: 113-118.
7. Biddle WL, Greenberger NJ, Swan JT et al (1988) 5-Aminosalicylic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitis. Gastroenterology 94: 1075-1079.
8. Björck S, Dahlström A & Ahlmann H (1989) Topical treatment of ulcerative proctitis with lidocaine. Scandinavian Journal of Gastroenterology 24: 1061-1072.
9. Björck S, Dahlström A, Johansson L et al (1992) Treatment of the mucosa with local anaesthetics in ulcerative colitis. Agents Actions, special conference issue: C60-C72.
10. Brattsand R (1990) Overview of newer glucocorticoid preparations for IBD. Canadian Journal of Gastroenterology 4: 407-414.
11. Breuer RI, Buto SK, Christ ML et al (1991) Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report. Digestive Diseases and Sciences 36: 185-187.
12. Breuer RI, Soergel KH, Lashner BA et al (1996) Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomized, placebo-controlled trial. Gastroenterology 110: A873.
13. Brynskov J, Freund L, Thomsen OO et al (1989) Treatment of refractory ulcerative colitis with cyclosporine enemas. Lancet i: 721-722.
14. Campieri M, Lanfranchi GA, Bertoni F et al (1984) A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis. Digestion 29: 204-208.
15. Campieri M, Lafranchi GA, Brignola C et al (1986) Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis. Diseases of the Colon and Rectum 29: 108-110.
16. Campieri M, Gionchetti P, Belluzzi A et al (1988) 5-Aminosalicylic acid enemas or suppositories in distal ulcerative colitis. Journal of Clinical Gastroenterology 10: 406-409.
17. Campieri M, Gionchetti P, Belluzzi A et al (1990a) Topical treatment of ulcerative colitis using enemas containing 5-aminosalicylic acid and beclomethasone dipropionate. Canadian Journal of Gastroenterology 4: 481-483.
18. Campieri M, DeFranchis R, Bianchi Porro G et al (1990b) Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial. Scandinavian Journal of Gastroenterology 25: 663-668.
19. Campieri M, Gionchetti P, Belluzzi A et al (1991a) Sucralfate, 5-aminosalicylic acid and placebo enemas in the treatment of distal ulcerative colitis. European Journal of Gastroenterology and Hepatology 3: 41-44.
20. Campieri M, Gionchetti P, Belluzzi A et al (1991b) Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Gut 32: 929-931.
21. Campieri M, Corbelli C, Gionchetti P et al (1992) Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis. Digestive Diseases and Sciences 37: 1890-1897.
22. Campieri M, Paoluzi P, D'Albasio G et al (1993) Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. Digestive Diseases and Sciences 38: 1843-1850.
23. Campieri M, Gionchetti P, Rizzello F et al (1996) A controlled randomized trial comparing oral versus rectal mesalazine in the treatment of ulcerative proctitis. Gastroenterology 110: A876.
24. D' Albasio G, Trallori G & Ghetti A (1990) Intermittent therapy with high-dose aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis. Diseases of the Colon and Rectum 33: 394-397.
25. Danielsson Å, Löfberg R, Persson T et al (1992) A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Scandinavian Journal of Gastroenterology 27: 9-12.
26. Danish 5-ASA Group (1987) Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis. Digestive Diseases and Sciences 32: 598-602.
27. Davies PS, Rhodes J, Heatley RV et al (1977) Metronidazole in the treatment of chronic proctitis: a controlled trial. Gut 18: 680-681.
28. Farthing MJ, Rutland JD & Clar JL (1979) Retrograde spread of hydrocortisone-containing foam given intrarectally in ulcerative colitis. British Medical Journal 2: 822-824.
29. Friedman G (1983) Tixocortol pivalate (JO 1016). American Journal of Gastroenterology 78: 529-530.
30. Friedman LS, Richter JM, Kirkham SE et al (1986) 5-aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial. American Journal of Gastroenterology 81: 412-418.
31. Frühmorgen P & Demling L (1980) On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon. Hepatogastroenterology 27: 473-476.
32. Ginsberg AL, Beck LS, McIntosh TM et al (1988) Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial. Annals of Internal Medicine 108: 195-199.
33. Grace RH, Gent AE & Hellier MD (1987) Comparative trial of sodium cromoglycate enemas with prednisolone enemas in the treatment of ulcerative colitis. Gut 28: 88-92.
34. Hanauer S, Borgen L & Reiss L (1992) Maintenance treatment of ulcerative proctitis with mesalamine suppositories: results of a multicenter two year controlled trial. Gastroenterology 104: A634.
35. Harig JM, Soergel KH, Komorowski RA & Wood CM (1989) Treatment of diversion colitis with short-chain fatty acid irrigation. New England Journal of Medicine 320: 23-28.
36. Jarlov AE, Munkholm P, Schmidt PN et al (1993) Treatment of active distal ulcerative colitis with immunoglobolin G enemas. Alimentary Pharmacology and Therapeutics 7: 561-565.
37. Järnerot G, Lennard-Jones J, Bianchi-Porro G et al (1991) Medical treatment of refractory distal ulcerative colitis. Gastroenterology International 4: 93-98.
38. Jay M, Digenis GA, Foster TS et al (1986) Retrograde spread of hydrocortisone enema in inflammatory bowel disease. Digestive Diseases and Sciences 31: 139-144.
39. Jewell DP (1989) Corticosteroids for the management of ulcerative colitis and Crohn's disease. Gastroenterology Clinics of North America 18: 21-33.
40. Kam L, Cohen H, Dooley C et al (1996) A comparison of mesalamine suspension enema and oral sulphasalazine for treatment of active distal ulcerative colitis in adults. American Journal of Gastroenterology 91: 1338-1342.
41. Kochhar R, Mehta SK, Aggarwal R et al (1990) Sucralfate enema in ulcerative rectosigmoid lesions. Diseases of the Colon and Rectum 33: 49-51.
42. Lee DAH, Taylor GM, James VHT & Walker G (1979) Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as retention enema. Gut 20: 349-335.
43. Lee DAH, Taylor M, James VHT & Walker G (1980) Rectally administered prednisolone - evidence for a predominantly local action. Gut 21: 215-218.
44. Lee FI, Jewell, DP, Mani V et al (1996) A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis. Gut 38: 229-233.
45. Lémann M, Galian A, Rutgeerts P et al (1995) Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis. Alimentary Pharmacology and Therapeutics 9: 557-562.
46. Löfberg R (1996) Combination therapy in active distal colitis - more studies are warranted. European Journal of Gastroenterology and Hepatology 8: 541-542.
47. Löfberg R, Østergaard Thomsen O, Langholz et al (1994) Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Alimentary Pharmacology and Therapeutics 8: 623-629.
48. Mantzaris GJ, Hatzis A, Petraki K et al (1994) Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in ulcerative proctitis and proctosigmoiditis. Diseases of the Colon and Rectum 37: 58-62.
49. Marshall JK & Irvine EJ (1995) Rectal aminosalicylate therapy for distal ulcerative colitis: a metaanalysis. Alimentary Pharmacology and Therapeutics 9: 293-300.
50. Marshall JK & Irvine EJ (1996) Rectal corticosteroids are not the best therapy for distal ulcerative colitis. Gastroenterology 110: A954.
51. McIntyre PB, Macrae FA, Berghouse L et al (1985) Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis. Gut 26: 822-824.
52. Miner P, Daly R, Nesto T et al (1994) The effect of varying dose intervals of mesalamine enemas for the prevention of relapse in distal ulcerative colitis. Gastroenterology 106: A736.
53. Mulder CJJ & Tytgat GNJ (1993) Review article: topical corticosteroids in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 7: 125-130.
54. Mulder CJJ, Endert E, van der Heide E et al (1989) Comparison of beclomethasone dipropionate (2 and 3 mg) and prednisolone sodium phosphate enemas (30 mg) in the treatment of ulcerative proctitis: an adrenocortical approach. Netherlands Journal of Medicine 35: 18-24.
55. Mulder CJJ, Fockens P, Meijer JWR et al (1996) Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis. European Journal of Gastroenterology and Hepatology 8: 549-553.
56. Ngo Y & Rambaud JC (1992) 5-Aminosalicylic acid enema (Pentasa) versus hydrocortisone acetate foam (Proctocort) for the treatment of outbreaks of proctitis and cryptogenic proctosigmoiditis. A comparative randomized multicenter trial. Gastroenterologie Clinique et Biologique 16: 558-563.
57. van Outryve M, Huble F, van Eeghem P et al (1996) Comparison of ridogrel versus prednisolone, both administered rectally, for the treatment of active ulcerative colitis. Gastroenterology 110: A1035.
58. Palmer KR, Goepel JR & Holdsworth CD (1981) Sulphasalazine retention enemas in ulcerative colitis: a double-blind trial. British Medical Journal 282: 1571-1573.
59. Patz J, Jacobsohn WZ, Gottschalk-Sabag S et al (1996) Treatment of refractory distal ulcerative colitis with short chain fatty acid enemas. American Journal of Gastroenterology 91: 731-734.
60. Pruitt R, Katz S, Bayless T & Levine J (1996) Repeated use of budesonide enema is safe and effective for the treatment of acute flares of distal ulcerative colitis. Gastroenterology 110: A995.
61. Pullan RD, Ganesh S, Mani V et al (1993) Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial. Gut 34: 676-679.
62. Riley SA, Gupta I, Mani V et al (1988) A comparison of sucralfate and prednisolone enemas in the treatment of active distal ulcerative colitis. Gastroenterology 94: A377.
63. Roediger WEW (1980a) Role of anaerobic bacteria in the metabolic welfare of the colonie mucosa in man. Gut 21: 793-798.
64. Roediger WEW (1980b) The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet ii: 712-715.
65. Ruddell WS, Dickenson RJ, Dixon MF & Axon AT (1980) Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut 21: 885-889.
66. Ryder SD, Walker RJ, Jones H et al (1990) Rectal bismuth subsalicylate as therapy for ulcerative colitis. Alimentary Pharmacology and Therapeutics 4: 333-338.
67. Sandborn WJ, Tremaine WJ, Schroeder KW et al (1993) Cyclosporine enemas for treatment-resistant, mildly to moderately active, left-sided ulcerative colitis. American Journal of Gastroenterology 88: 640-645.
68. Sandborn WJ, Tremaine WJ, Schroeder KW et al (1994) A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis. Gastroenterology 106: 1429-1435.
69. Scheppach W, for the German-Austrian SCFA Study Group (1996) Treatment of distal ulcerative colitis with short-chain fatty acid enemas: a placebo-controlled trial. Digestive Diseases and Sciences 41: 2254-2259.
70. Scheppach W, Sommer H, Kirchner T et al (1992) Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103: 51-56.
71. Schreiber S, Heinig T, Thiele HG & Raedler A (1995) Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 108: 1434-1444.
72. Selby WS, Bennet MK & Jewell DP (1984) Topical treatment of distal ulcerative colitis with 4-aminosalicylic acid enemas. Digestion 29: 231-234.
73. Senagore AJ, MacKeigan JM, Schneider M et al. (1992) Short-chain fatty acid enemas: a costeffective alternative in the treatment of nonspecific proctosigmoiditis. Diseases of the Colon and Rectum 35: 923-927.
74. Shah SA & Peppercorn MA (1996) A comparative review of topical therapies for inflammatory bowel disease. Clinical Immunotherapy 6: 117-129.
75. Somerville KW, Langman MJS, Kane SP et al (1985) Effect of treatment on symptoms and quality of life in patients with ulcerative colitis: comparative trial of hydrocortisone acetate foam and prednisolone 21-phosphate enemas. British Medical Journal 291: 866.
76. Sutherland LR (1990) Topical treatment of ulcerative colitis. Medical Clinics of North America 74: 119-131.
77. Sutherland LR, Martin F, Greer S et al (1987) 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92: 1894-1898.
78. Tarpila S, Turunen U, Seppälä K et al (1994) Budesonide enema in active haemorrhagic proctitis - a controlled trial against hydrocortisone foam enema. Alimentary Pharmacology and Therapeutics 8:591-595.
79. Truelove SC (1956) Treatment of ulcerative colitis with local hydrocortisone. British Medical Journal 2: 1267-1272.
80. Vernia P, Marcheggiano A, Caprilli R et al (1995) Short-chain fatty acid topical treatment in distal ulcerative colitis. Alimentary Pharmacology and Therapeutics 9: 309-313.
81. Vitti RA, Meyers F, Knight LC et al (1989) Quantitative distribution of radiolabeled 5-aminosalicylic acid enemas in patients with left-sided ulcerative colitis. Digestive Diseases and Sciences 34: 1792-1797.
82. 99mTc-labelled 5-ASA suppositories. Digestive Diseases and Sciences 32: S71-S75.